Gain Therapeutics, Inc.
GANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819411
No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Gain Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +2 vs. Q1 2025
- Shares held
- 3.79M
- +977.2K (+34.8%) vs. Q1 2025
- Total value
- $6.49M
- +$1.42M (+28.1%) vs. Q1 2025
- New holders
- 6
- 11 more added
- Sold out
- 4
- 5 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 50 | $17.4M |
| Q1 2026 | 42 | $15.8M |
| Q4 2025 | 48 | $25.9M |
| Q3 2025 | 38 | $7.70M |
| Q2 2025 | 35 | $6.49M |
| Q1 2025 | 33 | $5.07M |
| Q4 2024 | 25 | $3.94M |
| Q3 2024 | 19 | $2.40M |
| Q2 2024 | 28 | $3.89M |
| Q1 2024 | 26 | $7.04M |
| Q4 2023 | 24 | $5.05M |
| Q3 2023 | 24 | $4.95M |
| Q2 2023 | 24 | $5.68M |
| Q1 2023 | 22 | $5.54M |
| Q4 2022 | 21 | $3.78M |
| Q3 2022 | 23 | $3.95M |
| Q2 2022 | 16 | $3.87M |
| Q1 2022 | 16 | $4.75M |
| Q4 2021 | 19 | $5.71M |
| Q3 2021 | 14 | $6.65M |
| Q2 2021 | 14 | $8.95M |
| Q1 2021 | 12 | $15.0M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Gain Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jones Financial Companies LLLP | 676,888 | $1.33M | 0.00% | +249,188+58.3% | Added |
| DME Capital Management, LPSuperinvestorGreenlight Capital | 566,130 | $1.02M | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 534,352 | $961.8K | 0.00% | +279,362+109.6% | Added |
| Geode Capital Management, LLC | 290,462 | $522.9K | 0.00% | +8,251+2.9% | Added |
| Marshall Wace, LLP | 276,433 | $497.6K | 0.00% | +80,407+41.0% | Added |
| Cambridge Investment Research Advisors, Inc. | 179,500 | $323.0K | 0.00% | +120,000+201.7% | Added |
| Citadel Advisors LLC | 161,816 | $291.3K | 0.00% | +142,797+750.8% | Added |
| BlackRock, Inc. | 112,507 | $202.5K | 0.00% | +28,100+33.3% | Added |
| Northern Trust Corp | 100,170 | $180.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 94,000 | $169.2K | 0.00% | +94,000 | New |
| Susquehanna International Group, LLP | 79,551 | $143.2K | 0.00% | −6,407−7.5% | Reduced |
| Morgan Stanley | 76,512 | $137.7K | 0.00% | −23,283−23.3% | Reduced |
| State Street Corp | 71,137 | $128.0K | 0.00% | 00.0% | Unchanged |
| Kovitz Investment Group Partners, LLC | 47,578 | $85.6K | 0.00% | 00.0% | Unchanged |
| Dauntless Investment Group, LLC | 46,000 | $82.8K | 0.39% | −79,584−63.4% | Reduced |
| Prelude Capital Management, LLC | 35,820 | $64.5K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 32,635 | $58.7K | 0.00% | −10,725−24.7% | Reduced |
| Bridgeway Capital Management, LLC | 30,004 | $54.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 23,801 | $43.0K | 0.00% | +23,801 | New |
| Benedict Financial Advisors Inc | 22,500 | $40.5K | 0.01% | +4,500+25.0% | Added |
| Sandhill Capital Partners LLC | 15,400 | $27.7K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 12,756 | $23.0K | 0.00% | +12,756 | New |
| GWM Advisors LLC | 10,600 | $19.1K | 0.00% | 00.0% | Unchanged |
| Armis Advisers, LLC | 10,750 | $18.6K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 6,401 | $11.5K | 0.00% | +6,401 | New |
| Simplex Trading, LLC | 5,657 | $10.0K | 0.00% | +2,213+64.3% | Added |
| Creekmur Asset Management LLC | 4,440 | $7.99K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 4,410 | $7.94K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,164 | $7.50K | 0.00% | +62+1.5% | Added |
| Wells Fargo & Company | 2,650 | $4.77K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 2,500 | $4.50K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 2,300 | $4.14K | 0.00% | +2,300 | New |
| State of Wyoming | 1,194 | $2.15K | 0.00% | +1,194 | New |
| Tower Research Capital LLC (TRC) | 945 | $1.70K | 0.00% | −1,487−61.1% | Reduced |
| Gotham Asset Management, LLC | 245,896 | – | – | +91,912+59.7% | Added |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −20,154−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,355−100.0% | Sold out |
| Sprott Inc. | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |